--- title: "STERIS (STE) stock listing, news and investor profile" url: "https://aibio.space/companies/steris/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "STERIS plc (NYSE: STE), United States. Listing facts, related biotech companies and news on aibio.space." --- STE STERIS plc NYSE · United States # STERIS (STE) news STERIS plc is a public biotech or pharmaceutical company listed on NYSE under the ticker STE, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest STERIS news We have not published a story on STERIS yet. When there is news, it will appear here. ## STERIS at a glance - **Ticker**: STE - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $482.3 million ### Related companies - [PRO DEX INC](https://aibio.space/companies/pro-dex/) NASDAQ: PDEX - [USANA HEALTH SCIENCES INC](https://aibio.space/companies/usana-health-sciences/) NYSE: USNA - [Intercure](https://aibio.space/companies/intercure/) NASDAQ: INCR - [PAVmed](https://aibio.space/companies/pavmed/) NASDAQ: PAVM - [SERA PROGNOSTICS, INC.](https://aibio.space/companies/sera-prognostics/) NASDAQ: SERA - [BioNexus Gene Lab](https://aibio.space/companies/bionexus-gene-lab/) NASDAQ: BGLC - [PyroGenesis Canada](https://aibio.space/companies/pyrogenesis-canada/) OTC: PYRGF - [Sensus Healthcare](https://aibio.space/companies/sensus-healthcare/) NASDAQ: SRTS ### Also on NYSE - [KONINKLIJKE PHILIPS NV](https://aibio.space/companies/koninklijke-philips/) PHG - [USANA HEALTH SCIENCES INC](https://aibio.space/companies/usana-health-sciences/) USNA - [HAEMONETICS CORP](https://aibio.space/companies/haemonetics/) HAE - [Organon & Co.](https://aibio.space/companies/organon/) OGN - [Arcus Biosciences](https://aibio.space/companies/arcus-biosciences/) RCUS - [UL Solutions](https://aibio.space/companies/ul-solutions/) ULS ## What STERIS does STERIS is a global provider of products and services that support patient care, with an emphasis on infection prevention. It sells consumables such as detergents, endoscopy accessories and barrier products, services such as equipment maintenance and outsourced instrument reprocessing, capital equipment such as sterilizers, surgical tables and automated endoscope reprocessors, and connectivity solutions including operating room integration. The company reports three segments. Healthcare serves sterile processing departments and procedural centers. Applied Sterilization Technologies provides contract sterilization and laboratory testing for medical device and pharmaceutical manufacturers. Life Sciences supports biopharmaceutical and medical device facilities focused on aseptic manufacturing, with products such as pharmaceutical detergents and vaporized hydrogen peroxide room decontamination systems. Its Dental segment was divested in fiscal 2025 and is presented as discontinued operations. Named competitors include 3M, Baxter, Boston Scientific, Ecolab, Stryker and Sterigenics. | Product or program | What it is | Stage | |---|---|---| | Automated endoscope reprocessing systems | Reprocessing and tracking systems for endoscopes | | | Sterilizers and washers | Capital equipment for sterile processing departments | | | Surgical tables | Equipment used in procedure rooms | | | Contract sterilization services | Sterilization and laboratory testing for device and pharmaceutical manufacturers | | | Vaporized hydrogen peroxide room decontamination systems | Life Sciences decontamination systems | | Summarised from the company's [10-K filed May 29, 2026](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/ste-20260331.htm). ## STERIS annual financials | Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 | |---|---|---| | Revenue | [$5.94 billion](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | [$5.46 billion](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | | Research and development | [$112.9 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | [$107.6 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | | Net income (loss) | [$782.3 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | [$614.6 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | | Cash from operations | [$1.34 billion](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | [$1.15 billion](https://www.sec.gov/Archives/edgar/data/1757898/000162828026039136/) | | Cash and equivalents | [$439.6 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026054830/) | [$171.7 million](https://www.sec.gov/Archives/edgar/data/1757898/000162828026006055/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $482.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about STERIS What is the ticker symbol of STERIS? STERIS plc trades under the ticker STE on NYSE. Where is STERIS listed? STERIS plc is listed on NYSE. Which country or territory is STERIS listed under? Our directory records STERIS plc under United States. Does aibio.space cover STERIS? aibio.space lists STERIS plc among 2,820 public biotech companies and publishes its news here as stories appear. What does STERIS develop? STERIS is a global provider of products and services that support patient care, with an emphasis on infection prevention. It sells consumables such as detergents, endoscopy accessories and barrier products, services such as equipment maintenance and outsourced instrument reprocessing, capital equipment such as sterilizers, surgical tables and automated endoscope reprocessors, and connectivity solutions including operating room integration. What is Automated endoscope reprocessing systems from STERIS? Automated endoscope reprocessing systems: Reprocessing and tracking systems for endoscopes What is Sterilizers and washers from STERIS? Sterilizers and washers: Capital equipment for sterile processing departments What was STERIS's revenue last year? $5.94 billion for the fiscal year ended Mar 31, 2026, as reported to the SEC. Is STERIS profitable? STERIS plc reported net income of $782.3 million for the fiscal year ended Mar 31, 2026, and generated $1.34 billion of cash from operations, per its annual report to the SEC. How much does STERIS spend on research and development? $112.9 million in the fiscal year ended Mar 31, 2026, per its annual report. How much cash does STERIS have? $482.3 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: STERIS Members talk about STERIS (STE). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at STERIS, newest first. Each line links the filing it comes from. 1. 2026-08-05 Distress Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.02,2.05,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1757898/000162828026053412/ste6302026ex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:STE on TradingView](https://www.tradingview.com/symbols/NYSE-STE/). ## Listing details STERIS plc is a public biotech or pharmaceutical company listed on NYSE under the ticker STE, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: STERIS plc - **Ticker**: STE - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/steris/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "STERIS (STE) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/steris/